Congress Program
07:30
Registration
08:30
Congress Opening & Welcome
Jacob Ablin, Israel and Piercarlo Sarzi-Puttini, Italy
08:40
Opening Lecture
08:40-09:10
Year in Review 2023
Marco Di Carlo
Polytechnic University of Marche, Italy
09:10
Session 1: Pathogenesis and Clinical Features
09:10-09:40
Fibromyalgia, Hypermobility, and the Quest for a 'Syndrome X of Pain'
Carlos Gropen Jr.
University Hospital of Brasilia, Brazil
09:40-10:10
Mitochondrial Pathology in Fibromyalgia
Jacob Ablin
Tel-Aviv Sourasky Medical Center, Israel
10:10-10:40
Neuroimmunology of Fibromyalgia and Chronic Pain
Franziska Denk
King's College London, UK
10:40-11:10
CPM deficiency in fibromyalgia: key findings and novel treatment directions
Liron Rabany
Theranica, Israel
11:10-11:40
Coffee Break, Exhibition & Poster Viewing
11:40
Session 2: Novel Technologies and Approaches in Fibromyalgia
11:40-12:10
The Potential of AI in Fibromyalgia Research
Thomas Hügle
University Hospital Lausanne, Switzerland
12:10-12:40
Non-Invasive Transcutaneous Vagus Nerve Stimulation for the Treatment of Fibromyalgia
Andrés Molero-Chamizo
University of Huelva, Spain
12:40-13:10
Central Sensitization and Nociplastic Pain: How Clinically Useful Are These Concepts?
Emanuel van den Broeke
KULeuven, Belgium
13:10-14:10
Lunch Break, Exhibition & Poster Viewing
14:10
Session 3: Pathogenetic and Treatment Modalities
14:10-14:40
Advancements in Medications for Fibromyalgia
Diego Fornasari
University of Milan, Italy
14:40-15:10
The Relationship Between Chronic Pain and Depression in Fibromyalgia
Riccardo Torta
University of Turin, Italy
15:10-15:40
Psychotherapy in fibromyalgia: The state of the art and new directions
Federica Galli
Sapienza University of Rome, Italy
15:40-16:10
Coffee Break, Exhibition & Poster Viewing
16:10
Session 4: Genetics and Environmental Factors
16:10-16:40
The Impact of Environment on Fibromyalgia Symptoms
Cristina Iannuccelli
Sapienza University of Rome, Italy
16:40-17:10
Concomitant Fibromyalgia in Rheumatic Diseases
Ori Elkayam
Tel Aviv Medical Center, Israel
17:10
Oral Presentations of Selected Abstracts I
17:10-17:20
Evaluation of memantine in patients with fibromyalgia from the Multidisciplinary Center at Namur Godinne University Hospital
17:20-17:30
Efficacy and Safety of TNX-102 SL (Sublingual Cyclobenzaprine) for the Treatment of Fibromyalgia: Results from the Phase 3 Randomized, Double-Blind, Placebo-Controlled RESILIENT Trial
17:30-17:40
A Model of Psychological Predictors of Central Sensitivity in Fibromyalgia: Effects on Physical and Psychological Quality of Life
17:40
End of Day One
08:30
Registration
09:00
Session 5: Socioeconomic and Psychological Aspects
09:00-09:30
Why Should(‘nt) the Diagnosis of Fibromyalgia be Given (Only) by a Rheumatologist
Merav Lidar
Sheba Medical Center, Israel
09:30-10:00
The Role of Stress in Fibromyalgia
Valerie Aloush
Tel Aviv Sourasky Medical Center, Israel
10:00-10:30
Multidisciplinary Approach in Fibromyalgia Treatment
Winfried Häuser
Klinikum Saarbrücken, Germany
10:30-11:00
Coffee Break, Exhibition & Poster Viewing
11:00
Session 6: Future Directions and Innovations
11:00-11:30
Emerging Technologies in Fibromyalgia Diagnosis and Treatment
Jacob Ablin
Tel-Aviv Sourasky Medical Center, Israel
11:30-12:00
Exploring the Interplay between Fibromyalgia, Nutrition, and the Microbiome
Shai Shtrozberg
Tel Aviv Sourasky Medical Center, Israel
12:00-12:30
Innovative Approaches in Fibromyalgia Management
Piercarlo Sarzi-Puttini
IRCCS Ospedale Galeazzi – Sant'Ambrogio, Italy
12:30-13:30
Lunch Break, Exhibition & Poster Viewing
13:30
Session 7: Open Discussions and Workshops
Moderators: Giustino Varrassi, Italy, Jacob Ablin, Israel and Piercarlo Sarzi-Puttini, Italy
13:30-14:30
Interactive Workshop on Fibromyalgia Management (All Speakers)
14:30-15:00
Open Discussion and Q&A with Experts
15:00-15:30
Coffee Break, Exhibition & Poster Viewing
15:30
Oral Presentations of Selected Abstracts II
15:30-15:40
Sexual Functioning and Satisfaction in Women with Fibromyalgia confronted with other Chronic Pain Conditions
15:40-15:50
Use of tVNS as New Therapeutic Option in a Cohort of Patients with Fibromyalgia Syndrome: a Pilot Study
15:50-16:00
Investigating Neutrophil-Neuron Interactions That Modulate Somatosensory Processing and Chronic Widespread Pain
16:00-16:10
Pain characteristics of patients with fibromyalgia: a comparison between gender and different emotional states (
Pre-Recorded)
Pre-Recorded)
16:10
Special Session: Open Discussion and Workshop on Patients Organizations
Chairs: José António P. Da Silva, Portugal, Piercarlo Sarzi-Puttini, Italy and Jacob Ablin, Israel
16:10-16:20
The Italian Experience (AISF-ODV)
Giuseppina Fabio
AISF ODV (Italian Association of Fibromyalgia Syndrome), Italy
16:20-16:30
The European Experience (ENFA)
Gunilla Goran
ENFA President, Sweden
16:30-16:40
Fibromyalgia respects no borders: the Brazilian experience
Caren Cunha
ANFIBRO, Brazil
16:40-16:50
Discussion/Q&A
16:50
Congress Roundup & Conclusion
Jacob Ablin, Israel and Piercarlo Sarzi-Puttini, Italy
17:00
End of Congress
